Our mission is to extend healthy productive longevity by transforming drug discovery and development with artificial intelligence software, significantly reducing the time and cost to bring life-saving medications to patients. Working with pharmaceutical and academic partners, we seek to accelerate and improve drug research and development efforts with our end-to-end, validated Pharma.AI platform and experienced team of scientists. Our goal is to facilitate a precision medicine future while developing an internal pipeline in core therapeutic areas including fibrosis, oncology, immunology and central nervous system disorders.
Global Partnerships, Global Presence

Insilico Medicine works with top tier pharmaceutical companies globally to advance their drug discovery and biomarker development programs. Since 2014, the Company has established partnerships with Sanofi, Fosun Pharma, Arvinas, Pfizer and many others. Insilico is committed to global scientific collaboration and is rapidly expanding its presence in innovative regions around the globe. Headquartered in Hong Kong, the Company has satellite offices in New York, Montreal, Hong Kong, Shanghai, Suzhou, Taipei, and Abu Dhabi.
Be the first to know our news!
Once a month you will learn about our latest features and hottest news.
And no spam of course.